Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Evaluating the symptoms of pelvic floor disorders in relation to the stage of pelvic organ prolapse and quality of life

Document Type : Original Article

Authors

1 Supporting the Family and the Youth of Population Research Core, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Clinical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Background: This study aimed to investigate the relationship between pelvic organ prolapse symptoms, the severity and location of the prolapse, and their impact on the quality of life of women referring to a pelvic floor disorders clinic.
Methods: In this cross-sectional and multi-center study, which was conducted at the pelvic floor disorders clinics of Ghaem (AS) and Imam Reza (AS) hospitals from February 20, 2019, to April 20, 2020, approximately 191 women with complaints of pelvic floor disorders were examined. Participants completed the pelvic floor distress index (PFDI) questionnaire, and prolapse severity was assessed using the pelvic organ prolapse quantification (POP-Q) system. The relationship between disease severity, prolapse stage, and quality of life was investigated. Data were analyzed using SPSS 16, with P-values of less than 0.05 considered significant.
Results: The average age of participants was 53.23 years (31 to 89 years), and 95 (49.7%) of the patients were postmenopausal. One hundred eighty patients (94.2%) had at least one urinary symptom, and 116 patients (61%) had at least one bowel symptom. A significant relationship was observed between the stages of anterior and posterior compartment prolapse and the severity of stress urinary incontinence (SUI) (P < 0.001). Additionally, the stages of anterior and posterior compartment prolapse were significantly linked to incomplete defecation (P values of 0.031 and 0.004, respectively) and fecal urgency (P values of < 0.001 and < 0.001, respectively). All urinary and defecatory symptoms, except urinary frequency, urinary incontinence during sexual intercourse, and fecal incontinence were significantly related to PFDI. A significant correlation was also found between PFDI and prolapse severity (r = 0.334).
Conclusion: Urinary, defecatory, and sexual symptoms had significant relationships with the severity and the stage of pelvic organ prolapse and with the PFDI.

Keywords

Main Subjects

References
  1. Jones HW, Rock JA. Te Linde’s Operative Gynecology. 12th ed. Philadelphia: Wolters Kluwer; 2019. p. 827.
  2. Schulten SF, Detollenaere RJ, IntHout J, Kluivers KB, Van Eijndhoven HW. Risk factors for pelvic organ prolapse recurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension. Am J Obstet Gynecol. 2022;227(2):252.e1-252.e9. doi: 10.1016/j. ajog.2022.04.017.
  3. Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783- 90. doi: 10.1007/s00192-013-2169-9.
  4. Carroll L, O’Sullivan C, Perrotta C, Fullen BM. Biopsychosocial profile of women with pelvic organ prolapse: a systematic review. Womens Health (Lond). 2023;19:17455057231181012. doi: 10.1177/17455057231181012.
  5. Mutungi T, Spitzer R, Origa M, Kayondo M, Kyakuhaire M, Nyiramugisha J. Prevalence of urogynecology symptoms in a rural population in Western-Uganda. J Obstet Gynaecol Can. 2019;41(5):727. doi: 10.1016/j.jogc.2019.02.214.
  6. Ghanbari Z, Pourali L, Deldar Pesikhani M, Darvish S, Ayati E, Mehrad Majd H, et al. The relationship between clinical symptoms with POP-Q stage. Iran J Obstet Gynecol Infertil. 2022;25(7):1-7. doi: 10.22038/ijogi.2022.21128.
  7. Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(4):655-84. doi: 10.1007/s00192-016- 3003-y.
  8. Hale DS, Fenner D. Consistently inconsistent, the posterior vaginal wall. Am J Obstet Gynecol. 2016;214(3):314-20. doi: 10.1016/j.ajog.2015.09.001.
  9. Augusto KL, Bezerra L, Murad-Regadas SM, Vasconcelos Neto JA, Vasconcelos CTM, Karbage SAL, et al. Defecatory dysfunction and fecal incontinence in women with or without posterior vaginal wall prolapse as measured by pelvic organ prolapse quantification (POP-Q). Eur J Obstet Gynecol Reprod Biol. 2017;214:50-5. doi: 10.1016/j.ejogrb.2017.04.039.
  10. Horst W, do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017;28(8):1165-70. doi: 10.1007/s00192- 016-3238-7.
  11. Munno GM, La Verde M, Lettieri D, Nicoletti R, Nunziata M, Fasulo DD, et al. Pelvic organ prolapse syndrome and lower urinary tract symptom update: what’s new? Healthcare (Basel). 2023;11(10):1513. doi: 10.3390/healthcare11101513.
  12. Jokhio AH, Rizvi RM, MacArthur C. Prevalence of pelvic organ prolapse in women, associated factors and impact on quality of life in rural Pakistan: population-based study. BMC Womens Health. 2020;20(1):82. doi: 10.1186/s12905-020- 00934-6.
  13. Hakimi S, Hajebrahimi S, Bastani P, Aminian E, Ghana S, Mohammadi M. Translation and validation of the pelvic floor distress inventory short form (PFDI-20), Iranian version. BMJ Open. 2017;7(Suppl 1):208. doi: 10.1136/ bmjopen-2016-015415.208.
  14. Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol. 2001;185(6):1332-7. doi: 10.1067/mob.2001.119078.
  15. Marinkovic SP, Stanton SL. Incontinence and voiding difficulties associated with prolapse. J Urol. 2004;171(3):1021- 8. doi: 10.1097/01.ju.0000111782.37383.e2.
  16. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369(9566):1027-38. doi: 10.1016/s0140- 6736(07)60462-0.
  17. Tan JS, Lukacz ES, Menefee SA, Powell CR, Nager CW. Predictive value of prolapse symptoms: a large database study. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(3):203-9. doi: 10.1007/s00192-004-1243-8.
  18. Burrows LJ, Meyn LA, Walters MD, Weber AM. Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol. 2004;104(5 Pt 1):982-8. doi: 10.1097/01. AOG.0000142708.61298.be.
  19. de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, et al. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn. 2010;29(1):30-9. doi: 10.1002/ nau.20858.
  20. Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(2):122-7. doi: 10.1007/ s00192-002-1024-1.
  21. Whitcomb EL, Lukacz ES, Lawrence JM, Nager CW, Luber KM. Prevalence of defecatory dysfunction in women with and without pelvic floor disorders. J Pelvic Med Surg. 2009;15(4):179-87. doi: 10.1097/SPV.0b013e3181b12e01.
  22. Ghetti C, Gregory WT, Edwards SR, Otto LN, Clark AL. Pelvic organ descent and symptoms of pelvic floor disorders. Am J Obstet Gynecol. 2005;193(1):53-7. doi: 10.1016/j. ajog.2004.12.004.
  23. Cetinkaya SE, Dokmeci F, Dai O. Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life. Int Urogynecol J. 2013;24(10):1645-50. doi: 10.1007/s00192-013-2072-4.

 

Journal of Kerman University of Medical Sciences
Volume 32
Pages 1-6
Files
Share
How to cite
Statistics